Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Neutral

Debt to Equity Rating

Sell

Price to Earnings Rating

Strong Buy

Analyst Rating

Buy

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Strong Buy

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Buy

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Genetron Holdings Limited ADS (GTH)

https://www.genetronhealth.com

Genetron Holdings Ltd is an oncology company in China. It is specialized in cancer molecular profiling and harnesses advanced technologies in molecular biology and data science to transform cancer treatment. The company's operating segment includes Diagnosis and monitoring - provision for LDT services; Diagnosis and monitoring - sale of IVD products and Development services. It generates maximum revenue from the Diagnosis and monitoring - provision for LDT services segment.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

06/19/2020

Market Cap

127,288,210

Shares Outstanding

474,370,000

Weighted SO

31,624,381

Total Employees

N/A

Upcoming Earnings

N/A

Beta

0.4980

Last Div

0.0000

Range

2.0802-4.05

Chg

0.0050

Avg Vol

51864

Mkt Cap

127288210

Exch

NASDAQ

Country

CN

Phone

86 10 5090 7500

DCF Diff

N/A

DCF

0.0000

Div Yield

0.0000

P/S

0.6323

EV Multiple

0.2999

P/FV

0.2283

Div Yield %

0.0000

P/E

-0.6254

PEG

-0.0204

Payout

0.0000

Current Ratio

1.8184

Quick Ratio

1.1270

Cash Ratio

0.4521

DSO

467.6405

DIO

252.9262

Op Cycle

720.5667

DPO

192.7581

CCC

527.8086

Gross Margin

0.4070

Op Margin

-0.8741

Pretax Margin

-0.9924

Net Margin

-0.9905

Eff Tax Rate

0.0019

ROA

-0.2045

ROE

-0.3651

ROCE

-0.3006

NI/EBT

0.9981

EBT/EBIT

1.1353

EBIT/Rev

-0.8741

Debt Ratio

0.0000

D/E

0.0000

LT Debt/Cap

0.0000

Total Debt/Cap

0.0000

Int Coverage

0.0000

CF/Debt

0.0000

Equity Multi

1.7859

Rec Turnover

0.7805

Pay Turnover

1.8936

Inv Turnover

1.4431

FA Turnover

1.1333

Asset Turnover

0.2064

OCF/Share

0.0000

FCF/Share

0.0000

Cash/Share

5.8563

OCF/Sales

0.0000

FCF/OCF

0.0000

CF Coverage

0.0000

ST Coverage

0.0000

CapEx Coverage

0.0000

Div&CapEx Cov

0.0000

P/BV

0.2283

P/B

0.2283

P/S

0.6323

P/E

-0.6254

P/FCF

0.0000

P/OCF

0.0000

P/CF

0.0000

PEG

-0.0204

P/S

0.6323

EV Multiple

0.2999

P/FV

0.2283

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Jan 17, 06:05 Genetron Health to Hold Extraordinary General Meeting of Shareholders GlobeNewswire Inc. Jan 08, 06:45 G1 Therapeutics Provides Corporate Update at the 42nd Annual J.P. Morgan Healthcare Conference GlobeNewswire Inc. Jan 02, 16:51 G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire Inc. Jan 02, 16:51 G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PennyStocks Dec 06, 14:48 Best Penny Stocks To Buy? 4 To Watch With Big News This Week PennyStocks Dec 06, 14:48 Best Penny Stocks To Buy? 4 To Watch With Big News This Week GlobeNewswire Inc. Dec 05, 09:26 G1 Therapeutics Presents New Post Hoc Analyses Indicating That Patients Who Previously Received Trilaciclib Have Improved Overall Survival with Subsequent Anticancer Therapy GlobeNewswire Inc. Dec 01, 16:27 G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire Inc. Nov 29, 20:37 G1 Therapeutics Announces Upcoming Presentation at the 2023 San Antonio Breast Cancer Symposium GlobeNewswire Inc. Nov 29, 20:37 G1 Therapeutics Announces Upcoming Presentation at the 2023 San Antonio Breast Cancer Symposium GlobeNewswire Inc. Nov 29, 20:37 G1 Therapeutics Announces Upcoming Presentation at the 2023 San Antonio Breast Cancer Symposium GlobeNewswire Inc. Nov 01, 06:30 G1 Therapeutics Provides Third Quarter 2023 Financial Results and Operational Highlights Seeking Alpha Nov 01, 00:36 Spirit-JetBlue And 14 Other Opportunities In The Merger Arbitrage Space PennyStocks Oct 31, 14:18 Penny Stocks To Buy Today? 4 To Watch Now

Revenue Product Segmentation